- Home
- AUST vs NRXS Comparison
AUST vs NRXS Comparison
Compare AUST & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | AUST | NRXS |
|---|---|---|
| Founded | 2020 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.0M | 25.8M |
| IPO Year | 2022 | 2023 |
Fundamental Metrics
Financial Performance| Metric | AUST | NRXS |
|---|---|---|
| Price | $1.78 | $2.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 98.0K | 51.1K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,362,320.00 |
| Revenue This Year | N/A | $31.05 |
| Revenue Next Year | N/A | $137.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 36.89 |
| 52 Week Low | $1.05 | $1.33 |
| 52 Week High | $2.94 | $6.20 |
Technical Indicators
Market Signals| Indicator | AUST | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 52.04 | 51.56 |
| Support Level | $1.75 | $2.63 |
| Resistance Level | $2.15 | $2.78 |
| Average True Range (ATR) | 0.17 | 0.14 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 39.45 | 66.69 |
Price Performance
Historical ComparisonAbout AUST Austin Gold Corp.
Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).